The effect of o-phenylenediamine on the biosynthesis of vitamin B12: a new vitamin B12 analogue
- 31 December 1954
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 59 (1), 79-82
- https://doi.org/10.1042/bj0590079
Abstract
Fermentations of Streptomyces griseus on a complex or a synthetic medium in the presence of o-phenylenediamine gave rise to the production of a new analogue of vitamin B12. The new substance was isolated in the form of red needles. Its absorption spectrum is practically identical with that of vitamin B12. Benziminazole was identified as a hydrolytic product. The new material is microbiologically (plate assay) more active than vitamin B12: the greater activity probably explains the apparently increased "vitamin B12" titres obtained by Dulaney and Williams (1953). The biosynthesis of true vitamin B12 is competitively inhibited by phenylenediamine. The biosynthesis of the new material in the presence of phenylenediamine is competitively inhibited by l:2-diamino-4:5-dimethylbenzene. The inhibition index lies somewhere between 160 and 320.Keywords
This publication has 6 references indexed in Scilit:
- The biosynthesis of a new vitamin B12 analogue.1954
- Biosynthesis of vitamin B12-like compounds.1954
- Some properties of vitamin B12-like factors from faeces. I. Characteristics of different fractions.1952
- Determination of Vitamin B 12 with a Mutant Strain of Escherichia coliScience, 1951
- SELECTIVE TOXICITY OF 1,2-DICHLORO-4,5-DIAMINOBENZENE: ITS RELATION TO REQUIREMENTS FOR RIBOFLAVIN AND VITAMIN B12The Journal of Experimental Medicine, 1951
- Inhibition of Synthesis of Vitamin B12 and of Riboflavin by 1,2-Dichloro-4, 5-diaminobenzene in Bacterial CulturesExperimental Biology and Medicine, 1950